Hypertension Treatment in Nigeria 2.0

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory, Nigeria. This program demonstrated significant improvements in hypertension treatment and control. HTN 2.0 will expand implementation of the HEARTS bundle to 5 new states in 5 geopolitical zones in Nigeria (Abia, Delta, Gombe, Jigawa, and Oyo) while also evaluating sustainment of hypertension control in the Federal Capital Territory.

NCT Number	NCT07351162
Lead Sponsor	Washington University School of Medicine Collaborators: University of Abuja Teaching Hospital, University of Abuja, National Heart, Lung, and Blood Institute (NHLBI)
Conditions	Hypertension (HTN)
Enrollment	10,000 participants
Start Date	2026-02-01
Primary Completion	2029-01-31 (estimated)
Study Completion	2030-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-20